Cargando...
Characterization of CD22 Expression in Acute Lymphoblastic Leukemia
BACKGROUND: CD22 is a B-lineage differentiation antigen that has emerged as a leading therapeutic target in acute lymphoblastic leukemia (ALL). PROCEDURE: Properties of CD22 expression relevant to therapeutic targeting were characterized in primary samples obtained from children and young adults wit...
Guardado en:
| Publicado en: | Pediatr Blood Cancer |
|---|---|
| Autores principales: | , , , , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
2015
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4405453/ https://ncbi.nlm.nih.gov/pubmed/25728039 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/pbc.25410 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|